151 related articles for article (PubMed ID: 32176267)
1. Complement Activation Levels Are Related to Disease Stage in AMD.
Heesterbeek TJ; Lechanteur YTE; Lorés-Motta L; Schick T; Daha MR; Altay L; Liakopoulos S; Smailhodzic D; den Hollander AI; Hoyng CB; de Jong EK; Klevering BJ
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):18. PubMed ID: 32176267
[TBL] [Abstract][Full Text] [Related]
2. Impact of the common genetic associations of age-related macular degeneration upon systemic complement component C3d levels.
Ristau T; Paun C; Ersoy L; Hahn M; Lechanteur Y; Hoyng C; de Jong EK; Daha MR; Kirchhof B; den Hollander AI; Fauser S
PLoS One; 2014; 9(3):e93459. PubMed ID: 24675670
[TBL] [Abstract][Full Text] [Related]
3. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Association Study Reveals Variants in CFH and CFHR4 Associated with Systemic Complement Activation: Implications in Age-Related Macular Degeneration.
Lorés-Motta L; Paun CC; Corominas J; Pauper M; Geerlings MJ; Altay L; Schick T; Daha MR; Fauser S; Hoyng CB; den Hollander AI; de Jong EK
Ophthalmology; 2018 Jul; 125(7):1064-1074. PubMed ID: 29398083
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration.
Saksens NT; Lechanteur YT; Verbakel SK; Groenewoud JM; Daha MR; Schick T; Fauser S; Boon CJ; Hoyng CB; den Hollander AI
PLoS One; 2016; 11(6):e0144367. PubMed ID: 27258093
[TBL] [Abstract][Full Text] [Related]
6. Systemic complement activation in age-related macular degeneration.
Scholl HP; Charbel Issa P; Walier M; Janzer S; Pollok-Kopp B; Börncke F; Fritsche LG; Chong NV; Fimmers R; Wienker T; Holz FG; Weber BH; Oppermann M
PLoS One; 2008 Jul; 3(7):e2593. PubMed ID: 18596911
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variants and Systemic Complement Activation Levels Are Associated With Serum Lipoprotein Levels in Age-Related Macular Degeneration.
Paun CC; Ersoy L; Schick T; Groenewoud JM; Lechanteur YT; Fauser S; Hoyng CB; de Jong EK; den Hollander AI
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7766-73. PubMed ID: 26641553
[TBL] [Abstract][Full Text] [Related]
8. Genetic control of the alternative pathway of complement in humans and age-related macular degeneration.
Hecker LA; Edwards AO; Ryu E; Tosakulwong N; Baratz KH; Brown WL; Charbel Issa P; Scholl HP; Pollok-Kopp B; Schmid-Kubista KE; Bailey KR; Oppermann M
Hum Mol Genet; 2010 Jan; 19(1):209-15. PubMed ID: 19825847
[TBL] [Abstract][Full Text] [Related]
9. Genetic and environmental risk factors for extramacular drusen.
Altay L; Subiras X; Lorés de Motta L; Schick T; Berghold A; Hoyng CB; den Hollander AI; Fauser S; Sadda SR; Liakopoulos S
Mol Vis; 2020; 26():661-669. PubMed ID: 33088170
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
[TBL] [Abstract][Full Text] [Related]
11. CRISPR Manipulation of Age-Related Macular Degeneration Haplotypes in the Complement System: Potential Future Therapeutic Applications/Avenues.
Salman A; McClements ME; MacLaren RE
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338978
[TBL] [Abstract][Full Text] [Related]
12. Genetic control of complement activation in humans and age related macular degeneration.
Hecker LA; Edwards AO
Adv Exp Med Biol; 2010; 703():49-62. PubMed ID: 20711706
[TBL] [Abstract][Full Text] [Related]
13. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
[TBL] [Abstract][Full Text] [Related]
14. Zinc supplementation inhibits complement activation in age-related macular degeneration.
Smailhodzic D; van Asten F; Blom AM; Mohlin FC; den Hollander AI; van de Ven JP; van Huet RA; Groenewoud JM; Tian Y; Berendschot TT; Lechanteur YT; Fauser S; de Bruijn C; Daha MR; van der Wilt GJ; Hoyng CB; Klevering BJ
PLoS One; 2014; 9(11):e112682. PubMed ID: 25393287
[TBL] [Abstract][Full Text] [Related]
15. Almost total protection from age-related macular degeneration by haplotypes of the Regulators of Complement Activation.
Williamson JF; McLure CA; Guymer RH; Baird PN; Millman J; Cantsilieris S; Dawkins RL
Genomics; 2011 Dec; 98(6):412-21. PubMed ID: 21855625
[TBL] [Abstract][Full Text] [Related]
16. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ;
JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084
[TBL] [Abstract][Full Text] [Related]
17. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
Rohrer B
Adv Exp Med Biol; 2018; 1074():45-51. PubMed ID: 29721926
[TBL] [Abstract][Full Text] [Related]
18. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population.
Momozawa Y; Akiyama M; Kamatani Y; Arakawa S; Yasuda M; Yoshida S; Oshima Y; Mori R; Tanaka K; Mori K; Inoue S; Terasaki H; Yasuma T; Honda S; Miki A; Inoue M; Fujisawa K; Takahashi K; Yasukawa T; Yanagi Y; Kadonosono K; Sonoda KH; Ishibashi T; Takahashi A; Kubo M
Hum Mol Genet; 2016 Nov; 25(22):5027-5034. PubMed ID: 28173125
[TBL] [Abstract][Full Text] [Related]
19. Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages.
Schick T; Altay L; Viehweger E; Hoyng CB; den Hollander AI; Felsch M; Fauser S
PLoS One; 2016; 11(6):e0156778. PubMed ID: 27257685
[TBL] [Abstract][Full Text] [Related]
20. Significance of C2/CFB variants in age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population.
Nakata I; Yamashiro K; Yamada R; Gotoh N; Nakanishi H; Hayashi H; Akagi-Kurashige Y; Tsujikawa A; Otani A; Saito M; Iida T; Oishi A; Matsuo K; Tajima K; Matsuda F; Yoshimura N
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):794-8. PubMed ID: 22232432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
